Mechanisms of host leukocyte-mediated Toxoplasma dissemination in its host
宿主白细胞介导的弓形虫在宿主体内传播的机制
基本信息
- 批准号:10623334
- 负责人:
- 金额:$ 46万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-05-17 至 2027-04-30
- 项目状态:未结题
- 来源:
- 关键词:2-tyrosineAcquired Immunodeficiency SyndromeActinsAdaptor Signaling ProteinAdhesivesAffectAnimal ModelAnimalsAttenuated VaccinesBar CodesBehaviorBindingBiochemicalBiochemistryBiological AssayBioluminescenceBlindnessBrainCRISPR/Cas technologyCell-Matrix JunctionCellsCellular biologyCessation of lifeCo-ImmunoprecipitationsComplexCytoskeletonCytosolDataDefectDendritic CellsDevelopmentDiseaseDisseminated Malignant NeoplasmDistantEquus caballusExhibitsFetusFoundationsGenesHIVHuman bodyImageImmuneImmune systemImmunocompromised HostIn VitroIndividualInfantInfectionInterventionKnowledgeLeukocytesLifeLuciferasesMeasuresMediatingMesenchymalMolecularMothersMusNCK adaptor protein 1NR0B2 geneNamesOrganPTPN11 genePTPN6 geneParasitesPathologyPathway interactionsPatientsPeptidesPersonsPhosphoric Monoester HydrolasesPolymersPopulationProcessProline-Rich DomainProtein KinaseProtein Tyrosine PhosphataseProteinsRecombinantsRegulationResearchRouteShuttle VectorsSiteStructureTestingTherapeutic InterventionTimeTissuesToxoplasmaToxoplasma gondiiToxoplasmosisTransplant RecipientsTyrosine PhosphorylationVaccinesWorkacute infectioncancer cellcell motilityfoodborneimmunosuppressedin vivoinnovationinsightloss of functionmigrationmutantnovelnovel therapeuticsparasite invasionpathogenpolymerizationpreventprotein protein interactionprotein purificationreceptorresponserhotransmission process
项目摘要
The intracellular parasite Toxoplasma gondii causes life-threatening disease in immunosuppressed or
transplant patients. Its pathology mainly relies on the dissemination of the parasite from the site of infection to
various essential organs, such as the brain, where it causes tissue destruction. T. gondii often uses a Trojan
Horse mechanism to facilitate its dissemination, during which it hijacks the host cell migration machinery to co-
opt host leukocytes as shuttling vectors. Exactly how T. gondii does so, however, is largely unknown. We
recently identified a novel T. gondii protein important for its dissemination, which we named TgWIP. We found
that upon invasion the parasite secreted TgWIP into the host cell cytosol, where TgWIP stimulated dendritic
cells to become hyper-migratory and undergo a mesenchymal to amoeboid transition (MAT). The process was
associated with a dramatic rearrangement of the actin cytoskeleton. The overall objective of this application is
to determine the molecular mechanisms by which TgWIP mediates T. gondii dissemination in the host. Our
central hypothesis is that TgWIP promotes dissemination by modulating leukocyte actin dynamics. This
hypothesis was formulated based on our preliminary data showing that TgWIP directly interacts with several
central regulators of the actin cytoskeleton involved in cell migration, including the WAVE regulatory complex
(WRC), the SH2-SH3 adaptor proteins Nck and Grb2, and the SHP1/2 tyrosine phosphatases. We will test our
hypothesis by pursuing two aims: 1) determine how TgWIP interacts with various actin regulators to modulate
host actin dynamics in vitro, and 2) determine how TgWIP enhances host leukocyte motility to facilitate
dissemination in vivo. Specifically, our team will combine biochemistry, cell biology, and animal models to
determine (i) how TgWIP directly interacts with the WRC, Nck, Grb2, and SHP1/2, and how the interactions
influence actin polymerization in vitro; (ii) how these interactions alter the migrative behaviors of primary
dendritic cells; and (iii) how disruption of these interactions influences in vivo dissemination of T. gondii in mice.
Our proposed research is innovative because it will unravel a novel mechanism by which TgWIP, as a newly
identified parasite effector unique to T. gondii, coordinates several distinct host actin regulators to reroute
leucocyte migration and facilitate T. gondii dissemination. Our work is significant because understanding the
molecular and biochemical mechanisms underlying T. gondii dissemination will lay the foundation for the
development of novel interventions that can directly target these mechanisms and block T. gondii
dissemination after acute infection or reactivation in AIDS or transplant patients or from the mother to the fetus.
This knowledge will be also important for the development of a safe, non-transmissible live vaccine that can
prevent T. gondii transmission from animals. Furthermore, by understanding how TgWIP promotes MAT in
infected DCs, our work will provide valuable insights into how other cells, such as metastatic cancer cells and
leukocytes, may use a similar mechanism to undergo MAT in response to diverse environmental conditions.
细胞内寄生虫刚地弓形虫在免疫抑制或
移植患者其病理学主要依赖于寄生虫从感染部位传播到
各种重要器官,如大脑,在那里它会导致组织破坏。T.弓形虫通常使用木马程序
马机制,以促进其传播,在此期间,它劫持宿主细胞迁移机制,以共同-
选择宿主白细胞作为穿梭载体。如何T。然而,弓形虫的这种作用在很大程度上是未知的。我们
最近发现了一种新的T.弓形虫的一种蛋白质,对它的传播很重要,我们将其命名为TgdR。我们发现
在入侵时,寄生虫将Tgl分泌到宿主细胞胞质溶胶中,在那里Tgl刺激树突状细胞,
细胞变得过度迁移并经历间充质向变形虫转变(MAT)。该过程
与肌动蛋白细胞骨架的剧烈重排有关。本申请的总体目标是
以确定Tgl介导T.弓形虫在宿主体内传播。我们
中心假设是Tglutamine通过调节白细胞肌动蛋白动力学促进播散。这
基于我们的初步数据,我们提出了一种假设,表明Tgl直接与几种
参与细胞迁移的肌动蛋白细胞骨架的中枢调节因子,包括WAVE调节复合物
(WRC)SH 2-SH 3衔接蛋白Nck和Grb 2,以及SHP 1/2酪氨酸磷酸酶。我们将测试
通过追求两个目标来实现这一假说:1)确定Tgl如何与各种肌动蛋白调节剂相互作用以调节
体外宿主肌动蛋白动力学,和2)确定Tgl如何增强宿主白细胞运动,以促进
体内传播。具体来说,我们的团队将联合收割机结合生物化学、细胞生物学和动物模型,
确定(i)Tgal如何直接与WRC、Nck、Grb 2和SHP 1/2相互作用,以及这些相互作用如何与WRC、Nck、Grb 2和SHP 1/2相互作用。
影响肌动蛋白聚合在体外;(ii)这些相互作用如何改变迁移行为的主要
树突状细胞;以及(iii)这些相互作用的破坏如何影响T.小鼠弓形虫感染
我们提出的研究是创新的,因为它将揭示一种新的机制,
鉴定了T.弓形虫,协调几种不同的宿主肌动蛋白调节剂,
白细胞迁移和促进T.弓形虫传播。我们的工作意义重大,因为了解
T.弓形虫的传播将为
开发新的干预措施,可以直接针对这些机制和阻断T。弓形虫
急性感染后的传播或艾滋病或移植患者的再激活或从母亲到胎儿。
这些知识对于开发安全的、非传染性的活疫苗也很重要,
预防T.从动物传播弓形虫。此外,通过了解Tgallet如何促进MAT,
感染的DC,我们的工作将提供有价值的见解,了解其他细胞,如转移性癌细胞,
白细胞可以使用类似的机制来响应于不同的环境条件而经历MAT。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Baoyu Chen其他文献
Baoyu Chen的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Baoyu Chen', 18)}}的其他基金
Signal Integration from Membranes to the Actin Cytoskeleton
从膜到肌动蛋白细胞骨架的信号整合
- 批准号:
10217192 - 财政年份:2018
- 资助金额:
$ 46万 - 项目类别:
Signal Integration from Membranes to the Actin Cytoskeleton
从膜到肌动蛋白细胞骨架的信号整合
- 批准号:
10470730 - 财政年份:2018
- 资助金额:
$ 46万 - 项目类别:
Signal Integration from Membranes to the Actin Cytoskeleton
从膜到肌动蛋白细胞骨架的信号整合
- 批准号:
9751336 - 财政年份:2018
- 资助金额:
$ 46万 - 项目类别:
Signal Integration from Membranes to the Actin Cytoskeleton
从膜到肌动蛋白细胞骨架的信号整合
- 批准号:
10623679 - 财政年份:2018
- 资助金额:
$ 46万 - 项目类别:
Signal Integration from Membranes to the Actin Cytoskeleton
从膜到肌动蛋白细胞骨架的信号整合
- 批准号:
9982353 - 财政年份:2018
- 资助金额:
$ 46万 - 项目类别:
相似海外基金
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
10219039 - 财政年份:2020
- 资助金额:
$ 46万 - 项目类别:
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9981476 - 财政年份:2019
- 资助金额:
$ 46万 - 项目类别:
IGF::OT::IGF RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
IGF::OT::IGF 针对获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9364184 - 财政年份:2016
- 资助金额:
$ 46万 - 项目类别:
Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) in Saskatchewan- Where are we now and what does the future hold?
萨斯喀彻温省的人类免疫缺陷病毒(HIV)和获得性免疫缺陷综合症(艾滋病)——我们现在在哪里以及未来会怎样?
- 批准号:
236932 - 财政年份:2011
- 资助金额:
$ 46万 - 项目类别:
Miscellaneous Programs
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554155 - 财政年份:1991
- 资助金额:
$ 46万 - 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554156 - 财政年份:1991
- 资助金额:
$ 46万 - 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW
获得性免疫缺陷综合症研究综述
- 批准号:
2063342 - 财政年份:1991
- 资助金额:
$ 46万 - 项目类别: